Are intravenous immunoglobulins really inappropriate in acquired von Willebrand syndrome?
- PMID: 22244008
- PMCID: PMC3417746
- DOI: 10.2450/2011.0091-11
Are intravenous immunoglobulins really inappropriate in acquired von Willebrand syndrome?
Comment on
-
Recommendations for the use of albumin and immunoglobulins.Blood Transfus. 2009 Jul;7(3):216-34. doi: 10.2450/2009.0094-09. Blood Transfus. 2009. PMID: 19657486 Free PMC article. No abstract available.
References
-
- Federici AB, Stabile F, Castaman G, et al. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches. Blood. 1998;92:2707–11. - PubMed
-
- Federici AB, Rand JH, Bucciarelli P, et al. Subcommittee on von Willebrand factor: acquired von Willebrand syndrome: data from an international registry. Thromb Haemost. 2000;84:345–9. - PubMed
-
- Federici AB. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome. Hum Immunol. 2005;66:422–30. - PubMed
-
- Tiede A, Rand JH, Budde U, et al. How I treat acquired von Willebrand syndrome. Blood. 2011;117:6777–95. - PubMed